Anergis Reports Positive Long-Term Clinical Efficacy of Lead Compound AllerT − Field-based trial with 196 patients shows significant reductions in seasonal allergy symptoms − Efficacy of AllerT in both dose groups ma - Lead compound - Document - PDFSEARCH.IO

First Page	Meta Content
	Anergis Reports Positive Long-Term Clinical Efficacy of Lead Compound AllerT − Field-based trial with 196 patients shows significant reductions in seasonal allergy symptoms − Efficacy of AllerT in both dose groups ma Add to Reading List Document Date: 2014-10-27 08:47:05 Open Document File Size: 581,47 KB Share Result on Facebook City EPALINGES / / Company Sunstone Capital / PME/Vinci Capital / Esperante Ventures / Anergis SA / / Country Switzerland / / Currency CHF / / Event FDA Phase / Funding / / IndustryTerm therapy of allergies / biopharmaceutical / pharmaceutical / dose groups / allergy treatment / / MedicalCondition allergy / allergies / allergic reaction / birch pollen allergies / novel / proprietary allergy / COP allergy / pollen allergies / house dust mite allergies / prevalent and fastest growing chronic conditions / anaphylactic reactions / seasonal allergy / hypersensitivity / proprietary ultra-fast allergy / novel birch pollen allergy / ragweed pollen allergies / / MedicalTreatment investigational treatment / / Person Vincent Charlon / / Position CEO / / Product lead / AllerT / / Technology antibodies / / SocialTag Immune system Allergen immunotherapy Allergy Allergen House dust mite Immunotherapy Medicine Immunology Allergology

Anergis Reports Positive Long-Term Clinical Efficacy of Lead Compound AllerT − Field-based trial with 196 patients shows significant reductions in seasonal allergy symptoms − Efficacy of AllerT in both dose groups maAdd to Reading List